Explore the detailed record of transactions filed by Epperly Melissa B, Chief Financial Officer. Director active across 1 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 13 reports have been logged. Total volume traded: €860k. The latest transaction was filed on 4 April 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Melissa B. Epperly is the Chief Financial Officer at Zentalis Pharmaceuticals, Inc. In this role, she oversees financial operations and ensures compliance with regulations. With expertise in finance, she plays a crucial role in the financial management of the company.